指南与共识主动脉疾病

腹主动脉瘤指南筛查执行率显著不足且可能受合并症影响

Guideline-based screening for abdominal aortic aneurysms is significantly underperformed and possibly impacted by medical comorbidities.
指南 / 共识 · J Vasc Surg · 2025-10-28

本研究基于TriNetX全国数据库,评估腹主动脉瘤(AAA)筛查不足的程度及其对破裂率的影响,并探讨既往合并症是否影响筛查。结果显示USPSTF、SVS及仅SVS符合人群的筛查率分别为3.98%、2.12%和0.83%,筛查与较低的AAA破裂率相关;倾向匹配后筛查组特定合并症患病率较高,而其他合并症较低。

要点

  • 指南符合人群的AAA筛查率极低,仅SVS标准符合者筛查率不足1%。
  • 遵循USPSTF或SVS指南进行筛查均与较低的AAA破裂率显著相关。
  • 合并症可能影响临床医生决定是否进行AAA筛查。

核心结论

  • 指南符合人群中实际接受AAA筛查的比例很小,基于SVS指南的筛查率更低。
  • 遵循各指南进行筛查均能有效降低AAA破裂率。
  • 合并症可能影响临床筛查决策。

研究设计与样本

  • 回顾性队列研究,查询TriNetX Analytics全国数据库。
  • 定义USPSTF符合人群(65-75岁男性吸烟者)、SVS符合人群(≥65岁任何吸烟者)及仅SVS符合人群(≥65岁女性吸烟者或≥75岁男性吸烟者)。
  • 筛查定义为符合期内接受超声检查,未筛查为符合条件但未接受超声。
  • 采用倾向评分匹配年龄、种族/民族和医疗使用情况。

主要发现

  • USPSTF、SVS和仅SVS符合人群的筛查率分别为3.98%、2.12%和0.83%。
  • 筛查与较低的AAA破裂率相关(USPSTF OR 0.416,SVS OR 0.499,仅SVS OR 0.717;每项P < .05)。
  • 倾向匹配后共分析109,444例患者,筛查组与未筛查组各54,722例。
  • 筛查组合并高脂血症(OR 2.17)、高血压(OR 1.7)、肥胖(OR 1.5)等的比率较高。
  • 筛查组截瘫(OR 0.43)、偏瘫(OR 0.7)、痴呆(OR 0.76)等的比率较低(均P ≤ .01)。

关键数值与推荐

  • USPSTF指南:65-75岁男性吸烟者。
  • SVS指南:≥65岁任何吸烟者。
  • 仅SVS符合:≥65岁女性吸烟者或≥75岁男性吸烟者。
  • 筛查率:USPSTF 3.98%,SVS 2.12%,仅SVS 0.83%。
  • AAA破裂OR:USPSTF 0.416,SVS 0.499,仅SVS 0.717(P < .05)。

临床怎么用

  • 应提高对指南符合人群的AAA筛查意识,尤其是SVS指南覆盖的人群。
  • 筛查决策需考虑合并症的影响,避免因合并症而低估筛查获益。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to define the level of underscreening of abdominal aortic aneurysms (AAAs) and its effect on rupture rates and elucidate if prior medical comorbidities may impact this. METHODS: The TriNetX Analytics National Database was queried. The US Preventative Services Task Force (USPSTF) guidelines of male smokers aged 65 to 75 years and the Society for Vascular Surgery (SVS) guidelines of any smoker aged ≥65 years were used. Family history of AAA was not used. Three populations were defined: USPSTF eligible (male smokers 65-75 years old), SVS eligible (any smoker ≥65 years old), and SVS-only eligible (female smokers ≥65 years old, male smokers ≥75 years old). For each population, we isolated screened and unscreened individuals. Screened patients were defined as those who underwent a screening ultrasound examination during the eligible period, and unscreened patients were those who met screening eligibility but did not undergo ultrasound examination as determined by Current Procedural Terminology/Healthcare Common Procedure Coding System codes. International Classification of Diseases, 10th edition, codes were used to identify AAA and comorbidities. Data were matched by propensity score for age, race/ethnicity, and medical use (primary care visits, laboratory orders, etc). RESULTS: Screening rates for USPSTF-eligible, SVS-eligible, and SVS-only eligible patients were 3.98%, 2.12%, and 0.83%, respectively. Screening according to USPSTF, SVS, and SVS-only guidelines were associated with lower AAA rupture rates (odds ratio [OR], 0.416, 0.499, and 0.717, respectively; P < .05 for each). After propensity matching, a total of 109,444 patients were analyzed with 54,722 patients in each cohort (screened and unscreened). The screened cohort had higher rates of hyperlipidemia (OR, 2.17), hypertension (OR, 1.7), obesity (OR, 1.5), neoplasms (OR, 1.37), inflammatory polyarthropathies (OR, 1.31), systemic connective tissue disorder (OR, 1.25), diabetes mellitus (OR, 1.24), chronic kidney disease (OR, 1.2), peripheral vascular disease (OR, 1.07), and coronary artery disease (OR, 1.06). There were lower rates of paraplegia (OR, 0.43), hemiplegia (OR, 0.7), dementia (OR, 0.76), myocardial infarction (OR, 0.81), and heart failure (OR, 0.87) in the screened cohort. Each of these factors attained statistical significance (P ≤ .01). CONCLUSIONS: A small percentage of screening-eligible patients were actually screened for AAAs, less so based on SVS guidelines. Screening from each guideline was effective in decreasing rupture rates. USPSTF guideline-based screened patients had higher rates of specific medical comorbidities, whereas a prior history of other comorbidities was less prevalent in screened patients. Medical comorbidities may influence clinical decisions to obtain AAA screening.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ramesh R, Stacey P, Alexander M, et al. Guideline-based screening for abdominal aortic aneurysms is significantly underperformed and possibly impacted by medical comorbidities. J Vasc Surg. 2025. PMID: 41167381. doi:10.1016/j.jvs.2025.10.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。